Application no. and date | 20785440.7 (espacenet) (Federated) (European Patent Register), 20200910 | Patent/reg. no. and date | DK/EP 3864053, 20230705 | Publication date | 20210818 | Priority no. and date | EP 19196789, 20190911, EP 20154736, 20200130 | EP pub. no. and date |
EP 3864053 20210818 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | P82737DK01 | Inventor | RAMANATHAN, Krishnan, c/o Novartis Pharma AG Postfach
4002 Basel, CH, HAERING, Dieter Adrian, c/o Novartis Pharma AG Postfach
4002 Basel, CH, BAGGER, Morten, c/o Novartis Pharma AG Postfach
4002 Basel, CH, MERSCHHEMKE, Martin, c/o Novartis Pharma AG Postfach
4002 Basel, CH, ZIEHN, Marina, c/o Novartis Pharma AG Postfach
4002 Basel, CH, PINGILI, Ratnakar, c/o Novartis Pharmaceuticals Corporation One Health Plaza East
Hanover, NJ 07936-1080, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61P 25/00 (2006.01) , A61P 25/28 (2006.01) , C07K 16/28 (2006.01) | Title | BEHANDLING AF RMS VED AT SKIFTE TERAPI | Int. application no. | EP2020075332 | Int. publication no. | WO2021048280 | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|